FDA Inspection 1084710 — Alcami Carolinas Corporation
The FDA completed an inspection of Alcami Carolinas Corporation on Mar 7, 2019 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wilmington, NC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)